Thirty clinical isolates of Burkholderia cepacia from cystic fibrosis (CF) patients in the UK and Denmark were characterised, together with other clinical isolates and laboratory strains of B. cepacia, B. gladioli and B. vietnamiensis. Outer-membrane protein (OMP) profiles were determined, and the organisms were typed genotypically by pulsed-field gel electrophoresis after DNA restriction analyses with XbaI and DraI. This latter method revealed four clusters among the clinical isolates studied; one of these contained isolates of the UK and intercontinental CF epidemic lineage ET12, a cluster which appeared to contain three subtypes. Each of the four clusters appeared less closely related to laboratory strains of B. cepacia than were laboratory strains of B. vietnamiensis, but more closely related to both these species than to B. gladioli. Two types of OMP profile were distinguished among the clinical isolates and strains, and were designated A and B. In type A isolates the major proteins had mol. wts of 39, 27 and 18 kDa. Type B strains additionally contained a group of proteins in the size range 80–90 kDa, although detection of these depended upon the conditions for sample denaturation. In most cases, the OMP type correlated with the genotype, suggesting that examination of OMPs might be of value in the initial characterisation of isolates.
GovanJ. R. W.,
DereticV. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
. Microbiol Rev1996; 60:539–574
VergheseA.,
Al-SammanM.,
NabhanD.,
NaylorA. D.,
RiveraM. Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection. Arch Intern Med1994; 154:2086–2091
MortensenJ. E.,
FisherM. C.,
LiPumaJ. J. .
Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol1995; 16:30–32
ButlerS. L.,
DohertyC. J.,
HughesJ. E.,
NelsonJ. W.,
GovanJ. R. W.Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?. J Clin Microbiol1995; 33:1001–1004
HobsonR.,
GouldI.,
GovanJ. W. R.Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media. Eur J Clin Microbiol Infect Dis1995; 14:908–911
LiPumaJ. J.,
DasenS. E.,
NielsonD. W.,
StemR. C.,
StullT. L. .
Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet1990; 330:1094–1096
OuchiK.,
AbeM.,
KaritaM.,
OguriT.,
IgariJ.,
NakazawaT. Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing. J Clin Microbiol1995; 33:2353–2357
MuhdiK.,
EdenboroughF. P.,
GumeryL. Outcome for patients colonised with Burkholderia cepacia in Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax1996; 51:374–377
SunL.,
JiangR.-Z.,
SteinbachS. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nature Med1995; 1:661–666
GotohN.,
NaginoK.,
WadaK.,
TsujimotoH.,
NishinoT.Burkholderia (formerly Pseudomonas) cepacia porin is an oligomer composed of two component proteins. Microbiology1994; 140:3285–3291
van AlphenL.,
van DamA.,
BolP.,
SpanjaardK.,
ZanenH. C. .
Types and subtypes of 73 strains of Haemophilus influenzae isolated from patients more than 6 years of age with meningitis in the Netherlands. J Infect1987; 15:95–101
ParrT. R.,
MooreR. A.,
MooreL. V.,
HancockR. E. W. Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother1987; 31:121–123
GrothuesD.,
TummlerB. New approaches in genome analysis by pulsed-field gel electrophoresis: application to the analysis of Pseudomonas species. Mol Microbiol1991; 5:2763–2776
LugtenbergB.,
MeijersJ.,
PetersR., , van der HoekP., , van AlphenL. Electrophoretic resolution of the ‘major outer membrane protein’ of Escherichia coli K12 into four bands. FEBS Lett1975; 58:254–258
VandammeP.,
HolmesB.,
VancanneytM. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis and proposal of Burkholderia multivorans sp nov. Int J Syst Bacteriol1997; 47:1188–1200
LacyD. E.,
SmithA. W.,
LambertP. A. .
Serum IgG response to an outer membrane porin protein of Burkholderia cepacia in patients with cystic fibrosis. FEMS Immunol Microbiol1997; 17:87–94
HancockR. E. W.,
MouatE. C. A.,
SpeertD. P. .
Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis. J Infect Dis1984; 149:220–226
TenoverF. C.,
ArbeitR. D.,
GoeringR. V. .
Interpreting chromosomal DNA restriction patterns producted by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol1995; 33:2233–2239
GaurD.,
WilkinsonS. G. .
Lipopolysaccharide from Burkholderia vietnamiensis strain LMG 6999 contains two polymers identical to those present in the reference strain for Burkholderia cepacia serogrpup O4. FEMS Microbiol Lett1997; 157:183–188
PittT. L.,
KaufmannM. E.,
PatelP. S.,
BengeL. C. A.,
GaskinS.,
LivermoreD. M. .
Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol1996; 44:203–210
BaxterI. A.,
LambertP. A.,
SimpsonI. N. .
Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli. J Antimicrob Chemother1997; 39:169–175
YohalemD. S.,
LorbeerX. W. .
Intraspecific metabolic diversity among strains of Burkholderia cepacia isolated from decayed onions, soils, and the clinical environment. Antonie van Leeuwenhoek1994; 65:111–131
YohalemD. S.,
LorbeerX. W. .
Multilocus isoenzyme diversity among strains of Pseudomonas cepacia isolated from decayed onions, soils, and clinical sources. Syst Appl Microbiol1994; 17:116–124
SimpsonI. N.,
FinlayJ.,
WinstanleyD. J. .
Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antimicrob Chemother1994; 34:353–361